SBIR/STTR Research Award

SBIR Phase I: Vertical Perfusion System for Cell Culture and Monitoring

Award identifier 2af0b38cf30b5bd1a93bb9709ca8ba204a5658fa8f086b37eb8beef1db63fa28Awarding agency National Science Foundation

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2006

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Science Foundation
Branch
Not reported
Recipient company
TauTheta Instruments LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
NSF 05-605
Topic code
BT

Research abstract

This Small Business Innovation Research (SBIR) Phase I project will attempt to show feasibility of a Vertical Perfusion Cartridge system to improve in vitro studies of diverse cell types, including insulin-producing Islets of Langerhans. Basic and applied cell physiology research could be advanced with the development of the proposed perfusion system. The aim is to develop a convenient, mass produced and easily used perfusion column cartridge that contains four to sixteen chambers. Modular construction of the assembly facilitates loading of the islets, controlling and maintain perfusion and performing real-time measurement of oxygen consumption rate (OCR), cytochrome-c oxidative state, NADH and other molecules via absorption/fluorescence spectroscopy in response to physiological perturbations. The proposed design will allow convenient sterilization, optionally reusable or disposable components, built-in oxygen sensors and associated instrumentation for real-time monitoring and recording of data. During Phase I, the plan is to design, build and evaluate one or more cartridge systems, using non-living cell-replicates and using live islets. Three significant commercial markets for the proposed technology are related to islet transplantation, basic islet research, and drug discovery, multi-billion dollar industries that pay a premium for methods capable of reducing development and operational risks. Two recent publications estimated the total real cost of islet transplantation procedures at $100,000 to $150,000 per patient, though the cost will fall over time as the procedures are refined. Nonetheless devices that either identify viable islets or assist in the development of such methods, or that speed research into alternative transplant methods, such as encapsulation, would quickly pay for themselves in cost savings. Applications related to islets include basic research into physiology and function, development and validation of drugs targeting islets, and assessment of islet viability prior to transplantation. Researchers who work on basic function and biology of islets will find this system useful because it enables the examination of multiple sets of islets simultaneously, thus improving statistical significance of their findings.

Technology keywords

Not reported

Agency intelligence

National Science Foundation

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.